Biostage, Inc.
Biostage, Inc. (BSTG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BSTG · as of Jun 9, 2026
Key Statistics
Explore Biostage, Inc. Data
bstg stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bstg competitorsBSTG
ETXPF
GDNSF
HRPMF
KDEVF
MCIOFStock Performance
Full HistoryAbout Biostage, Inc.
Biostage, Inc. is a biotechnology enterprise dedicated to developing medical products aimed at curing patients suffering from cancers, injuries, and congenital defects within the gastrointestinal syst…
what is biostage, inc. · bstg stock overview · biostage, inc. company profile · who is biostage, inc. ceo · bstg OTC · biostage, inc. headquarters · biostage, inc. business segments
About Stock Overview & Key Data
Biostage, Inc. (BSTG) is a Healthcare company in the Biotechnology industry, listed on OTC since Oct 21, 2013. As of the latest trading session, BSTG stock price is $4.03, with a market capitalization of $57.8M. The stock has returned -11.43% over the past 12 months and -40.84% year-to-date.
In fiscal year 2025, Biostage, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biostage, Inc. (BSTG) stock price is $4.03. The stock is traded on OTC under the ticker symbol BSTG. The 52-week range is $3.65 – $9.00.